Northeast Dairy Foods Research Center, Department of Food Science, Cornell University, Ithaca, NY 14853.
Northeast Dairy Foods Research Center, Department of Food Science, Cornell University, Ithaca, NY 14853.
J Dairy Sci. 2013 Apr;96(4):2020-2034. doi: 10.3168/jds.2012-6007. Epub 2013 Feb 15.
Small pore microfiltration (MF) can be used to remove serum proteins (SP) from skim milk. The process's SP removal efficiency directly influences the technology's economic feasibility. Our objective was to quantify the capacity of 0.14μm ceramic Isoflux MF membranes (TAMI, Nyons, France) to remove SP from skim milk. A 3-stage, 3×, feed-and-bleed MF study with diafiltration in the latter 2 stages was conducted at 50°C using Isoflux membranes to determine cumulative SP removal percentages and SP removal rates at each processing stage. The experiment was replicated 3 times starting with 3 separate lots of raw milk. In contrast to 3× MF theoretical cumulative SP removal percentages of 68, 90, and 97% after 1, 2, and 3 stages, respectively, the 3× Isoflux MF process removed only 39.5, 58.4, and 70.2% of SP after 1, 2, and 3 stages, respectively. Previous research has been published that provides the skim milk SP removal capacities of 3-stage, 3× 0.1μm ceramic Membralox (Pall Corp., Cortland, NY) uniform transmembrane pressure (UTP), 0.1μm ceramic Membralox graded permeability (GP), and 0.3μm polymeric polyvinylidene fluoride spiral-wound (PVDF-SW) MF systems (Parker-Hannifin, Process Advanced Filtration Division, Tell City, IN) at 50°C. No difference in cumulative SP removal percentage after 3 stages was detected between the Isoflux and previously published PVDF-SW values (70.3%), but SP removal was lower than published GP (96.5%) and UTP (98.3%) values. To remove 95% of SP from 1,000kg of skim milk in 12h it would take 7, 3, 3, and 7 stages with 6.86, 1.91, 2.82, and 17.98m(2) of membrane surface area for the Isoflux, GP, UTP, and PVDF-SW systems, respectively. The MF systems requiring more stages would produce additional permeate at lower protein concentrations. The ceramic MF systems requiring more surface area would incur higher capital costs. The authors hypothesize that SP removal with the Isoflux membranes was lower than theoretical for the following reasons: a range of membrane pore sizes existed (i.e., some pores were too small to pass SP), the selective layer modification and reverse flow conditions at the membrane outlet combined to reduce the effective membrane surface area, and the geometric shape of the Isoflux flow channels promoted early fouling of the membrane and rejection of SP by the foulant.
微孔过滤(MF)可用于从脱脂乳中去除血清蛋白(SP)。该工艺的 SP 去除效率直接影响到技术的经济可行性。我们的目的是定量评估 0.14μm 陶瓷 Isoflux MF 膜(TAMI,尼永,法国)从脱脂乳中去除 SP 的能力。在 50°C 下,使用 Isoflux 膜进行 3 阶段、3×、进料和渗滤的 3×MF 研究,以确定每个处理阶段的累积 SP 去除百分比和 SP 去除率。该实验重复了 3 次,使用了 3 批不同的原料乳。与 3×MF 理论上的累积 SP 去除率分别为 68%、90%和 97%相比,3×Isoflux MF 工艺仅在第 1、2 和 3 阶段分别去除了 39.5%、58.4%和 70.2%的 SP。先前的研究已经发表,提供了 3 阶段、3×0.1μm 陶瓷 Membralox(Pall Corp.,科特兰,NY)均相跨膜压力(UTP)、0.1μm 陶瓷 Membralox 分级渗透率(GP)和 0.3μm 聚合物聚偏二氟乙烯螺旋缠绕(PVDF-SW)MF 系统(帕克-汉尼汾,先进过程过滤部门,泰尔城,IN)在 50°C 下的脱脂乳 SP 去除能力。在 3 个阶段后,Isoflux 和先前发表的 PVDF-SW 值之间的累积 SP 去除百分比没有差异(70.3%),但 SP 去除率低于发表的 GP(96.5%)和 UTP(98.3%)值。要在 12 小时内从 1000kg 脱脂乳中去除 95%的 SP,Isoflux、GP、UTP 和 PVDF-SW 系统分别需要 7、3、3 和 7 个阶段,以及 6.86、1.91、2.82 和 17.98m(2)的膜表面积。需要更多阶段的 MF 系统将在较低的蛋白质浓度下产生更多的渗透物。需要更多表面积的陶瓷 MF 系统将产生更高的资本成本。作者假设,由于以下原因,用 Isoflux 膜去除 SP 的效果低于理论值:存在一系列的膜孔径(即,一些孔太小而无法通过 SP),膜出口处的选择性层修饰和反向流动条件结合起来降低了有效膜表面积,以及 Isoflux 流道的几何形状促进了膜的早期污染和对 SP 的排斥。